Srinivasan Venkatesh 4
4 · SUTRO BIOPHARMA, INC. · Filed Apr 12, 2024
Insider Transaction Report
Form 4
Srinivasan Venkatesh
CHIEF TECH OP OFFICER
Transactions
- Tax Payment
Common Stock
2024-04-11$4.50/sh−7,582$34,119→ 30,122 total - Exercise/Conversion
Common Stock
2024-04-11+21,250→ 37,704 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2024-04-11−21,250→ 42,500 totalExp: 2026-04-11→ Common Stock (21,250 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total shares annually beginning on April 11, 2023, subject to continued service through each vesting date.